Human Genome Epidemiology Literature Finder
Records 1 - 7 (of 7 Records) |
Query Trace: Thrombocytopenia and ABCC2[original query] |
---|
Association of ABCC2 polymorphisms with platinum-based chemotherapy response and severe toxicity in non-small cell lung cancer patients. Lung cancer (Amsterdam, Netherlands) 2011 May 72 (2): 238-43. Han Baohui, Gao Ge, Wu Wenting, Gao Zhiqiang, Zhao Xueying, Li Ling, Qiao Rong, Chen Hongyan, Wei Qingyi, Wu Jinchang, Lu Da |
Association of ABCC2 -24C>T polymorphism with high-dose methotrexate plasma concentrations and toxicities in childhood acute lymphoblastic leukemia. PloS one 2014 9 (1): e82681. Liu Yan, Yin You, Sheng Qi, Lu Xiaotong, Wang Fang, Lin Zhiyan, Tian Huaiping, Xu Ajing, Zhang Ji |
Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancer. BMC pharmacology & toxicology 2015 16 2. Lambrechts Sandrina, Lambrechts Diether, Despierre Evelyn, Van Nieuwenhuysen Els, Smeets Dominiek, Debruyne Philip R, Renard Vincent, Vroman Philippe, Luyten Daisy, Neven Patrick, Amant Frédéric, Leunen Karin, Vergote Ignace, |
Polymorphisms in SLCO1B1 and UGT1A1 are associated with sorafenib-induced toxicity. Pharmacogenomics 2016 09 17 (14): 1483-90. Bins Sander, Lenting Anne, El Bouazzaoui Samira, van Doorn Leni, Oomen-de Hoop Esther, Eskens Ferry Alm, van Schaik Ron Hn, Mathijssen Ron |
Association of ABCC2 with levels and toxicity of methotrexate in Malaysian Childhood Acute Lymphoblastic Leukemia (ALL). Pediatric hematology and oncology 2019 Dec 1-13. Razali Rizal Husaini, Noorizhab Mohd Nur Fakhruzzaman, Jamari Hisyam, James Richard Johari, Teh Kok Hoi, Ibrahim Hishamshah Mohd, Teh Lay Kek, Salleh Mohd Za |
Irinotecan-Induced Toxicity: A Pharmacogenetic Study Beyond UGT1A1. Clinical pharmacokinetics 2023 9 . Mirjam de With, Leni van Doorn, Esmay Kloet, Anne van Veggel, Maja Matic, Micha J de Neijs, Esther Oomen-de Hoop, Esther van Meerten, Ron H N van Schaik, Ron H J Mathijssen, Sander Bi |
Genetic polymorphisms as predictive biomarkers of adverse events during preoperative chemotherapy in esophageal cancer. Cancer chemotherapy and pharmacology 2023 10 . Yao Liang, Osamu Maeda, Kazushi Miyata, Mitsuro Kanda, Shizuki Sugita, Dai Shimizu, Kazuki Nishida, Yasuhiro Kodera, Yuichi An |
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 25, 2024
- Content source: